Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
MEDIBIOFARMA SL logo — To make disease-modifying treatments available to patients w...

MEDIBIOFARMA SL

To make disease-modifying treatments available to patients with serious or life-threatening conditions

Founded 2016 Spain Spain 8 employees Series Unknown Total: $2.42M Biotechnology, Health Care

General Information

Company Name MEDIBIOFARMA SL
Founded Year 2016
Location Spain Spain
Employees 8
Industries Biotechnology, Health Care
Funding Stage Series Unknown
Social

Get notified when MEDIBIOFARMA SL moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About MEDIBIOFARMA SL

MEDIBIOFARMA SL is a clinical-stage biotechnology company founded in 2016 by a group of professionals with extensive experience in Drug Discovery in the pharmaceutical industry. The company's slogan "To make disease-modifying treatments available to patients with serious or life-threatening conditions" encapsulates its vision. Medibiofarma aims to generate innovative and high-quality research programs based on the modulation of clinically validated therapeutic targets for the treatment of cancer and non-cancer diseases. Specializing in Biotechnology and Health Care, the company is headquartered in Spain. The latest investment, a grant investment at 20 March 2023, came from the Crohn's & Colitis Foundation. This shows the confidence that notable organizations have in MEDIBIOFARMA SL's potential to develop disease-modifying treatments.

Taxonomy: clinical-stage, research programs, drug discovery, therapeutic targets, cancer treatment, non-cancer diseases, disease-modifying treatments, pharmaceutical industry, innovation, lifethreatening conditions, Medibiofarma S.L, biopharmaceutical, medical research

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 2
Investor Investor
03 Apr 2024
Grant •••••• 1
Investor
20 Mar 2023
Venture Round •••••• 1
Investor
15 Mar 2022
Funding Round •••••• 1
Investor
01 Jan 2020
Funding Round •••••• 1
Investor
01 Jan 2019

MEDIBIOFARMA SL Alternatives & Competitors

MEDIBIOFARMA SL vs
Rutgers Cancer Institute
Rutgers Cancer Institute United States

Rutgers Cancer Institute is committed to providing the most advanced, comprehensive, and compassiona...

Grant
909 employees
Health Care
MEDIBIOFARMA SL vs
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota United States

The Twin Cities' only NCI-designated comprehensive cancer center. #UMNCancer

192 employees
Education, Health Care
MEDIBIOFARMA SL vs
Breast Cancer Trials
Breast Cancer Trials Australia

We do the research, so that no more lives are cut short from breast cancer | #nomorelivescutshort

65 employees
Health Care

FAQ About MEDIBIOFARMA SL

To make disease-modifying treatments available to patients with serious or life-threatening conditions
MEDIBIOFARMA SL was founded in 2016.
MEDIBIOFARMA SL is headquartered in Spain.
MEDIBIOFARMA SL operates in the following industries: Biotechnology, Health Care.
MEDIBIOFARMA SL has approximately 8 employees.
MEDIBIOFARMA SL has completed 5 funding rounds, raising a total of $2.42M. The latest funding stage is Series Unknown.
Top alternatives and competitors to MEDIBIOFARMA SL include Rutgers Cancer Institute, Masonic Cancer Center, University of Minnesota, Breast Cancer Trials, CancerTools.org (CancerToolsOrg), San Antonio Breast Cancer Symposium. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MEDIBIOFARMA SL and Rutgers Cancer Institute are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors MEDIBIOFARMA SL and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy